DE69208888D1 - N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten - Google Patents

N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten

Info

Publication number
DE69208888D1
DE69208888D1 DE69208888T DE69208888T DE69208888D1 DE 69208888 D1 DE69208888 D1 DE 69208888D1 DE 69208888 T DE69208888 T DE 69208888T DE 69208888 T DE69208888 T DE 69208888T DE 69208888 D1 DE69208888 D1 DE 69208888D1
Authority
DE
Germany
Prior art keywords
trityl
production
acid derivatives
nmda antagonists
asparagic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69208888T
Other languages
English (en)
Other versions
DE69208888T2 (de
Inventor
Jeffrey Whitten
Duane Rudisill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69208888D1 publication Critical patent/DE69208888D1/de
Application granted granted Critical
Publication of DE69208888T2 publication Critical patent/DE69208888T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69208888T 1991-11-15 1992-10-13 N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten Expired - Fee Related DE69208888T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79283491A 1991-11-15 1991-11-15
PCT/US1992/008739 WO1993010075A1 (en) 1991-11-15 1992-10-13 N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists

Publications (2)

Publication Number Publication Date
DE69208888D1 true DE69208888D1 (de) 1996-04-11
DE69208888T2 DE69208888T2 (de) 1996-08-01

Family

ID=25158215

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69208888T Expired - Fee Related DE69208888T2 (de) 1991-11-15 1992-10-13 N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten

Country Status (16)

Country Link
EP (1) EP0613459B1 (de)
JP (1) JP3168563B2 (de)
KR (1) KR100241480B1 (de)
AT (1) ATE134989T1 (de)
AU (1) AU667845B2 (de)
CA (1) CA2121835A1 (de)
DE (1) DE69208888T2 (de)
DK (1) DK0613459T3 (de)
ES (1) ES2087555T3 (de)
FI (1) FI942248A (de)
GR (1) GR3019587T3 (de)
HU (1) HU214055B (de)
IL (1) IL103710A (de)
MX (1) MX9206448A (de)
NO (1) NO305314B1 (de)
WO (1) WO1993010075A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU632362B2 (en) * 1989-09-19 1992-12-24 Merrell Dow Pharmaceuticals Inc. Nmda antagonists

Also Published As

Publication number Publication date
IL103710A (en) 1998-02-08
MX9206448A (es) 1993-05-01
FI942248A0 (fi) 1994-05-13
ES2087555T3 (es) 1996-07-16
HU9401469D0 (en) 1994-08-29
NO941820D0 (no) 1994-05-13
NO305314B1 (no) 1999-05-10
WO1993010075A1 (en) 1993-05-27
ATE134989T1 (de) 1996-03-15
EP0613459B1 (de) 1996-03-06
JP3168563B2 (ja) 2001-05-21
CA2121835A1 (en) 1993-05-27
KR100241480B1 (ko) 2000-03-02
NO941820L (no) 1994-05-13
DE69208888T2 (de) 1996-08-01
AU667845B2 (en) 1996-04-18
JPH07501523A (ja) 1995-02-16
HUT70551A (en) 1995-10-30
EP0613459A1 (de) 1994-09-07
GR3019587T3 (en) 1996-07-31
DK0613459T3 (da) 1996-04-01
FI942248A (fi) 1994-05-13
IL103710A0 (en) 1993-04-04
AU2864292A (en) 1993-06-15
HU214055B (en) 1997-12-29

Similar Documents

Publication Publication Date Title
DE68919053T2 (de) Verfahren zur Herstellung von Aluminoxanen.
DE69615453T2 (de) Verfahren zur Herstellung von mikrokapselhaltigen Zusammensetzungen
NO905608L (no) Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater.
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
DE69011739D1 (de) Verfahren zur Herstellung von Phosphatidsäure.
DE59208629D1 (de) Verfahren zur Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227)
DE69228330D1 (de) Verfahren zur Herstellung von Waschmittelzusammensetzungen
DE68907438T2 (de) Verfahren zur Herstellung von Waschmittelzusammensetzungen.
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
DE69104220D1 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
DE69901519T2 (de) Verfahren zur Herstellung von 2,2'-bis (Hydroxymethyl)alkansäure
DE69208888D1 (de) N-trityl asparaginsäurederivate zur herstellung von phosphonat nmda antagonisten
DE69531554D1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE58906606D1 (de) Optisch aktive Rhodiumkomplexe von 3,4-Bis(diarylphosphino)-pyrrolidinen und ihre Verwendung zur Herstellung von Phosphinothricin durch asymmetrische Hydrierung.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE59010187D1 (de) Verfahren zur Herstellung von substituierten 2,4-Diamino-6-fluor-s-triazinen
DE59003418D1 (de) Verfahren zur Herstellung von reinen C4-C7-tert.-Alkenen.
DE59104571D1 (de) Verfahren zur Herstellung von Vinylphosphonsäurederivaten.
DE69007362D1 (de) Verfahren zur Herstellung von staubfreiem Natriumdithionit.
GR1001309B (el) Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης.
DE69200795D1 (de) Verfahren zur Herstellung von L-Prolinederivaten.
DE59203733D1 (de) Verfahren zur Herstellung von substituierten Hexensäuren.
DE69106579T2 (de) Verfahren zur Herstellung von trimerem Dichloracetaldehyd.
DE69024906T2 (de) Verfahren zur gleichzeitigen Herstellung von 2,5- und 2,6-Dichlortoluol
ATE113589T1 (de) Verfahren zur herstellung von pyrimidintrionderivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee